The vaccination against Ebola of high-risk populations began on Monday in Côte d’Ivoire following the discovery of an outbreak in the country three days ago. The swift response came after vaccines manufactured by Merck, which the World Health Organization (WHO) helped to secure to fight a four-month long outbreak in neighbouring Guinea, were quickly sent to the country.
LIECHTENSTEIN: ‘We Have One of the Strictest Abortion Bans in Europe’ 
Nuclear Victims’ Experiences Must Be at the Heart of Global Efforts for Assistance and Remediation 
New reservoir offers innovative solution to South Sudan cattle beef 
‘Advance safety for all’: International police cooperation helps tackle cross-border crime 
Midwives: The Workforce That Will Determine Maternal and Newborn Survival and Africa’s Future 
Bridging Digital Transformation in an ASEAN-EAEU Cooperation